Which drugs does patent 9,279,794 protect, and when does it expire?
Patent 9,279,794 protects INOMAX and is included in one NDA. There has been one Paragraph IV challenge on INOmax.
Protection for INOMAX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has seven patent family members in seven countries.